Company intelligence / Profile preview

Well-healthcare Technologies

Hangzhou, Zhejiang, Chinawell-healthcare.com ↗

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Their diagnostic systems have entered real-world studies for lung nodule malignancy differentiation and colorectal cancer early screening. The peptidomics diagnostic system is under registration procedures. No therapeutic drugs or interventional devices reported.

Therapeutic areas: PulmonologyOncologyOther
Modalities: DeviceMass Spectrometry
Industry: Protein Biomarker Diagnostics

Partnerships

Strategic cooperation with Zhejiang University (industry-university-research collaboration)Graduate internship base for Department of Chemistry at Zhejiang University

Beyond the preview

Go deeper on Well-healthcare Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Well-healthcare Technologies.

Explore the full profile